Seeff LB - Search Results

1

Seeff LB. Seeff LB. Hepatology. 2002 Nov;36(5 Suppl 1):S35-46. doi: 10.1053/jhep.2002.36806. Hepatology. 2002. PMID: 12407575 Review.

2

The history of the "natural history" of hepatitis C (1968-2009).

Seeff LB. Seeff LB. Liver Int. 2009 Jan;29 Suppl 1(0 1):89-99. doi: 10.1111/j.1478-3231.2008.01927.x. Liver Int. 2009. PMID: 19207971 Free PMC article. Review.

3

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group. Freedman ND, et al. Hepatology. 2009 Nov;50(5):1360-9. doi: 10.1002/hep.23162. Hepatology. 2009. PMID: 19676128 Free PMC article.

4

Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.

Ghany MG, Kim HY, Stoddard A, Wright EC, Seeff LB, Lok AS; HALT-C Trial Group. Ghany MG, et al. Among authors: seeff lb. Hepatology. 2011 Nov;54(5):1527-37. doi: 10.1002/hep.24550. Hepatology. 2011. PMID: 22045670 Free PMC article.

5

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, Ishak KG, Iber FL, Toro D, Samanta A, Koretz RL, Perrillo RP, Goodman ZD, Knodell RG, Gitnick G, Morgan TR, Schiff ER, Lasky S, Stevens C, Vlahcevic RZ, Weinshel E, Tanwandee T, Lin HJ, Barbosa L. Seeff LB, et al. Hepatology. 2001 Feb;33(2):455-63. doi: 10.1053/jhep.2001.21905. Hepatology. 2001. PMID: 11172349

6

Natural history of hepatitis C.

Seeff LB. Seeff LB. Am J Med. 1999 Dec 27;107(6B):10S-15S. doi: 10.1016/s0002-9343(99)00374-5. Am J Med. 1999. PMID: 10653449

7

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group. Seeff LB, et al. Hepatology. 2008 Feb;47(2):605-12. doi: 10.1002/hep.22044. Hepatology. 2008. PMID: 18157835 Free article. Clinical Trial.

8

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group. Welzel TM, et al. Hepatology. 2009 Jun;49(6):1847-58. doi: 10.1002/hep.22877. Hepatology. 2009. PMID: 19434718 Free PMC article.

9

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB; American Association for Study of Liver Diseases. Ghany MG, et al. Among authors: seeff lb. Hepatology. 2011 Oct;54(4):1433-44. doi: 10.1002/hep.24641. Epub 2011 Sep 26. Hepatology. 2011. PMID: 21898493 Free PMC article. No abstract available.

10

Complementary and alternative medicine in chronic liver disease.

Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH. Seeff LB, et al. Hepatology. 2001 Sep;34(3):595-603. doi: 10.1053/jhep.2001.27445. Hepatology. 2001. PMID: 11526548 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page